71
Views
6
CrossRef citations to date
0
Altmetric
Original Research

An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial

, , , , , , & show all
Pages 2097-2103 | Published online: 18 Dec 2012

References

  • HigginbothamEJSchumanJSGoldbergIOne-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertensionArch Ophthalmol20021201286129312365906
  • AptelFCucheratMDenisPEfficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trialsJ Glaucoma20081766767319092464
  • ParrishRKPalmbergPSheuWPGroupXLTSA comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter studyAm J Ophthalmol200313568870312719078
  • KymesSMBurkCFeinmanTWilliamsJMHollanderDADemonstration of an online tool to assist managed care formulary evidence-based decision making: meta-analysis of topical prostaglandin analog efficacyTher Clin Risk Manag2011728329021845051
  • NoeckerRSDirksMSChoplinNTA six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucomaAm J Ophthalmol2003135556312504698
  • LawSKSongBJFangECaprioliJFeasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance OrganizationOphthalmology20051122123213016225924
  • CravenERLiuCCBatoosinghASchiffmanRMWhitcupSMA randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprostClin Ophthalmol201041433144021188155
  • HolloGThe side effects of the prostaglandin analoguesExpert Opin Drug Saf20076455217181451
  • KatzLJCohenJSBatoosinghALFelixCShuVSchiffmanRMTwelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertensionAm J Ophthalmol2010149661671e66120346780
  • PfennigsdorfSRamezOvon KistowskiGMulticenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertensionClin Ophthalmol2012673974622654501
  • LealBCMedeirosFAMedeirosFWSantoRMSusannaRJrConjunctival hyperemia associated with bimatoprost use: a histopathologic studyAm J Ophthalmol200413831031315289152
  • ChenJDinhTWoodwardDFBimatoprost: mechanism of ocular surface hyperemia associated with topical therapyCardiovasc Drug Rev20052323124616252016
  • AstinMStjernschantzJSelenGRole of nitric oxide in PGF2 alpha-induced ocular hyperemiaExp Eye Res1994594014077532135
  • PatelSCSpaethGLCompliance in patients prescribed eyedrops for glaucomaOphthalmic Surg1995262332367651690